Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • SearchUnify Reviews & Ratings
    150 Ratings
    Company Website
  • SDS Manager Reviews & Ratings
    4 Ratings
    Company Website
  • Infor M3 Reviews & Ratings
    156 Ratings
    Company Website
  • InfoBox Reviews & Ratings
    47 Ratings
    Company Website
  • AlisQI Reviews & Ratings
    108 Ratings
    Company Website
  • optivalue.ai Reviews & Ratings
    4 Ratings
    Company Website
  • SciSure Reviews & Ratings
    311 Ratings
    Company Website
  • ManageEngine ADAudit Plus Reviews & Ratings
    629 Ratings
    Company Website
  • Visual Visitor Reviews & Ratings
    251 Ratings
    Company Website
  • Gushwork Reviews & Ratings
    29 Ratings
    Company Website

What is SILCS?

Site-Identification by Ligand Competitive Saturation (SILCS) generates three-dimensional representations called FragMaps, which depict the interactions of various chemical functional groups with a designated target molecule. By uncovering the intricacies of molecular dynamics, SILCS provides essential tools that facilitate the refinement of ligand scaffolds, offering both qualitative and quantitative perspectives on binding sites, which ultimately aids in optimizing the drug design workflow. This methodology utilizes a selection of small molecule probes, each possessing a variety of functional groups, along with explicit solvent modeling and the flexibility of the target molecule to effectively map protein targets. Moreover, the technique empowers researchers to visualize beneficial interactions with the target macromolecule, allowing for a more informed design process. Armed with these insights, scientists can strategically engineer enhanced ligands with functional groups positioned for maximum efficacy. The pioneering approach of SILCS marks a noteworthy leap forward in the realm of medicinal chemistry, opening new avenues for drug discovery and development. Through its advanced analytical capabilities, SILCS not only enhances understanding but also drives innovation in therapeutic design.

What is BenevolentAI?

BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Standard Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub

Training Options

Documentation Hub
Online Training

Company Facts

Organization Name

SilcsBio

Date Founded

2012

Company Location

United States

Company Website

silcsbio.com/software/

Company Facts

Organization Name

BenevolentAI

Date Founded

2013

Company Location

Luxembourg

Company Website

www.benevolent.com

Categories and Features

Drug Discovery

Not specified

Categories and Features

AI Science

Not specified

Drug Discovery

Not specified

Life Sciences

Not specified

Popular Alternatives

Aurora Drug Discovery Reviews & Ratings

Aurora Drug Discovery

Aurora Fine Chemicals

Popular Alternatives

3decision Reviews & Ratings

3decision

Discngine
LigPlot+ Reviews & Ratings

LigPlot+

EMBL-EBI
Scitara DLX Reviews & Ratings

Scitara DLX

Scitara